Company profile
Home - Predictive Health Intelligence
Predictive Health Intelligence is changing how doctors find patients at risk but unaware of their condition first in liver disease.
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
Next accounts due date
CS01 | Transaction MzUzMDA5OTM4NmFkaXF6a2N4
Published 02 Jul 2026 15:46
Next confirmation statement due date
ANNOTATION | Transaction MzUyNjE3MTQ0MWFkaXF6a2N4 | Paper/PDF filed
Published 10 Jun 2026 08:30
ANNOTATION | Transaction MzUyNjE3MTI4OGFkaXF6a2N4 | Paper/PDF filed
Published 10 Jun 2026 08:29
PSC06 | Transaction MzQ3MjE3ODEzM2FkaXF6a2N4
Published 10 Jun 2026 08:30
PSC03 | Transaction MzQ3MDU4NDYwN2FkaXF6a2N4
Published 10 Jun 2026 08:28
Last confirmation statement made up date
Last accounts made up date
AA | Transaction MzQ0MTEyOTc2MGFkaXF6a2N4
Published 28 Oct 2024 02:58
Company registered at Companies House
1 Sep 2023 to 31 Aug 2025
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are becoming increasingly prevalent in the UK, with an estimated 20% of the adult population affected. These conditions are associated with obesity and type 2 diabetes, and can lead to serious liver damage, including cirrhosis and liver cancer. The cost of treating liver di...
